Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2012
11/20/2012US8313740 Methods for treating cancer with a recombinant MVA expressing HER-2
11/20/2012CA2448796C Vaccine against the nile fever virus
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/20/2012CA2343653C Recombinant newcastle disease virus rna expression systems and vaccines
11/15/2012WO2012154756A2 Delaying the progression of diabetes
11/15/2012WO2012154698A2 Method to improve antiviral activity of nucleotide analogue drugs
11/15/2012WO2012154271A2 Method and cells for identifying rig-i pathway regulators
11/15/2012WO2012153854A1 Cytokine-chemokine modulator
11/15/2012WO2012153635A1 Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient
11/15/2012WO2012153193A2 Protein-active agent conjugates and method for preparing the same
11/15/2012WO2012152632A1 Minimal retrovirus vector system
11/15/2012WO2012151609A1 Method of treatment and prophylaxis of pathologies of the bone
11/15/2012WO2012129394A9 Methods and compositions for the treatment of cancer
11/15/2012WO2012119051A9 Enhanced biodistribution of oligomers
11/15/2012WO2012078586A9 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
11/15/2012WO2012070008A3 Recombinant proteins with a selective inactivation activity on target proteins
11/15/2012WO2012052872A3 Methods and compositions for the treatment of insulin-associated medical conditions
11/15/2012WO2012051431A3 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
11/15/2012US20120288943 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/2012US20120288942 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/2012US20120288941 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/2012US20120288931 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/15/2012US20120288537 Active self-healing biomaterial system
11/15/2012US20120288526 Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods
11/15/2012US20120288509 Analysis of methylated nucleic acid
11/15/2012US20120288505 Gene delivery
11/15/2012US20120288472 Regulation of t cell-mediated immunity by tryptophan
11/15/2012CA2835576A1 Protein-active agent conjugates and method for preparing the same
11/14/2012EP2523002A1 Utilization of magnetic nanoparticles as intracellular pull-down system
11/14/2012EP2522723A1 Custom-made meganuclease and use thereof
11/14/2012EP2522364A1 Method of treating hemolytic disease
11/14/2012EP2522363A1 Method of treating hemolytic disease
11/14/2012EP2522362A1 Method of treating hemolytic disease
11/14/2012EP2522361A1 Method of treating hemolytic disease
11/14/2012EP2522360A1 Vaccine for treatment of tautopathy
11/14/2012EP2521785A2 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
11/14/2012EP2521784A2 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/14/2012EP2521555A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
11/14/2012CN1960707B Liposomal assembly for therapeutic and/or diagnostic use
11/14/2012CN102782139A Novel therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
11/14/2012CN102782135A Treatment of RNase H1 related diseases by inhibition of natural antisense transcript to RNase H1
11/14/2012CN102782134A Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
11/14/2012CN102781480A Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
11/14/2012CN102778566A Application of DLK1 in diagnosis and prognosis of liver cancer
11/14/2012CN102776285A Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-alpha
11/14/2012CN102776235A Recombinant expression plasmid and application thereof in preparing anti-tumor immunogene therapeutic medicament
11/14/2012CN102776188A Structure and application of target RAF1 (c-Raf, v-raf-leukemia viral oncogene 1) anti-encephalitis-b-virus oligonucleotides
11/14/2012CN102776187A Structure and application of anti-EV71 (enterovirus 71) oligonucleotides
11/14/2012CN102776176A Small interference RNAs for human GSK-3beta gene and application thereof
11/14/2012CN102776155A Chinese isolated strain of bovine enterovirus, and construction and application of infectious cDNA clone thereof
11/14/2012CN102775530A RAFT (reversible addition fragmentation chain transfer) preparation method of polylysine derivative
11/14/2012CN102775496A Composite medicine for targeted elimination of HIV/SIV
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102775490A Secretory protein with migration activity and application thereof
11/14/2012CN102775487A Artificial targeted fusion protein and protein conjugate, and preparation method and application thereof
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102772806A Application of micromolecular nucleic acid miR-302 for treating or preventing testicular cancer
11/14/2012CN102772805A Application of product capable of restraining MPG expression for enabling cell to stay at first gap (G1)
11/14/2012CN102772804A Application of MAOA (monoamine oxidase) gene in liver cancer treatment
11/14/2012CN102772803A Applications of UNC5CL and its coding protein
11/14/2012CN102772797A Genetic engineering polypeptide vaccine for 4 subtypes of O-type foot and mouth disease virus and its application
11/14/2012CN102772796A Genetic engineering polypeptide vaccine for Myanmar subtype-containing 3 subtypes in O-type foot and mouth disease virus, its preparation and application
11/14/2012CN102772793A Brucella deoxyribonucleic acid (DNA) vaccine as well as construction method and application thereof
11/14/2012CN102329794B Bcl11a siRNA-585 for inhibiting B-cell lymphoma/leukemia 11A (BCL11A) expression and tumorous B cell proliferation and application thereof
11/14/2012CN102242122B Nucleic acid aptamer specifically combined with HCV (hepatitis C virus) non-structural protein NS2, and application thereof
11/14/2012CN102218146B ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
11/14/2012CN102206677B Construction and application of overexpression vector of mouse adiponectin gene
11/14/2012CN101892237B Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
11/14/2012CN101618212B Gene vaccine of tuberculosis multivalence epitope and application thereof
11/14/2012CN101445802B Novel porcine circovirus virus, vaccines and diagnosis agent
11/14/2012CN101164623B Methods for concentrating virus preparations
11/14/2012CN101123994B Therapeutic uses of inhibitors of rtp801
11/14/2012CN101080487B Mature dendritic cell compositions and methods for culturing same
11/13/2012US8309796 Chimeric PUFA polyketide synthase systems and uses thereof
11/13/2012US8309705 Methods and compositions for enhancing the efficacy and specificity of RNA silencing
11/13/2012US8309704 Mediates silencing of a target gene; lessening the base pair strength between the 5' end of the first strand and the 3' end of a second strand of the duplex as compared to the base pair strength
11/13/2012US8309533 Allele-specific RNA interference
11/13/2012US8309531 Administration of interferon for prophylaxis against or treatment of pathogenic infection
11/13/2012US8309528 Two pore channels as regulators of proliferation in cancer
11/13/2012US8309355 Methods of treating Parkinson's disease using viral vectors
11/13/2012US8309071 Foamy viral envelope genes
11/13/2012CA2641565C Nel-related proteins type 1 and 2, and polynucleotides encoding them
11/13/2012CA2397675C Altered strain of the modified vaccinia virus ankara (mva)
11/08/2012WO2012151575A2 A method of controlling coagulation
11/08/2012WO2012151537A2 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012125828A3 Methods of treating breast cancer with anthracycline therapy
11/08/2012WO2012125405A9 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
11/08/2012WO2012092569A3 Compositions comprising immunostimulatory nucleic acids and related methods
11/08/2012US20120283319 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/08/2012US20120283167 Ev576 for use in the treatment of viral infections of the respiratory tract
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282343 Compositions for oral gene therapy and methods of using same
11/08/2012US20120282230 Methods and compositions for diagnosis and treatment of genetic and retinal disease
11/08/2012US20120282226 Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012DE102011100581A1 Behandlung von hyperproliferativen Erkrankungen des Urogenitaltraktes Treatment of hyperproliferative disorders of the genitourinary tract
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012EP2520311A2 Method of treating hemolytic disease
11/07/2012EP2520302A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 870